Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Medicare IVIG Access and Strengthening Medicare and Repaying Taxpayers Act of 2012
Client: BAXTER HEALTHCARE CORPORATION · Firm: BAXTER HEALTHCARE CORPORATION
HR 1845/S 960: Provide supplies and nursing services necessary for home infusion of IVIG to Medicare beneficiaries with Primary Immunodeficiency Diseases; Legislation to cut Medicare Part B Drug Reimbursement.Raise awareness with legislators about the barriers to and the importance of protecting reimbursement for home dialysis.
Medicare IVIG Access and Strengthening Medicare and Repaying Taxpayers Act of 2012
Client: BAXTER HEALTHCARE CORPORATION · Firm: BAXTER HEALTHCARE CORPORATION
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
BAXTER HEALTHCARE CORPORATION via BAXTER HEALTHCARE CORPORATION
2012 · fourth_quarter · Q4
HR 1845/S 960: Provide supplies and nursing services necessary for home infusion of IVIG to Medicare beneficiaries with Primary Immunodeficiency Diseases; Legislation to cut Medicare Part B Drug Reimbursement.Raise awareness with legislators about the barriers to and the importance of protecting access for home dialysis.HR 3613: Part D Beneficiary Appeals Fairness Act - Amends part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act, with respect to a prescription drug plan (PDP) that provides for any tiered cost-sharing within a formulary (including a structure that provides for different co-payment or coinsurance amounts for drugs in different tiers included within the formulary), to authorize a Medicare part D eligible individual enrolled in the plan to request an exception to the tiered cost-sharing structure.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Source: Senate LDA
HR 1845/S 960: Provide supplies and nursing services necessary for home infusion of IVIG to Medicare beneficiaries with Primary Immunodeficiency Diseases; Legislation to cut Medicare Part B Drug Reimbursement.Raise awareness with legislators about the barriers to and the importance of protecting access for home dialysis.
Medicare IVIG Access and Strengthening Medicare and Repaying Taxpayers Act of 2012
Client: BAXTER HEALTHCARE CORPORATION · Firm: BAXTER HEALTHCARE CORPORATION
HR 1845/S 960: Provide supplies and nursing services necessary for home infusion of IVIG to Medicare beneficiaries with Primary Immunodeficiency Diseases; Legislation to cut Medicare Part B Drug Reimbursement.Raise awareness with legislators about the barriers to and the importance of protecting access for home dialysis. HR 3613: Part D Beneficiary Appeals Fairness Act - Amends part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act, with respect to a prescription drug plan (PDP) that provides for any tiered cost-sharing within a formulary (including a structure that provides for different co-payment or coinsurance amounts for drugs in different tiers included within the formulary), to authorize a Medicare part D eligible individual enrolled in the plan to request an exception to the tiered cost-sharing structure.
Medicare IVIG Access and Strengthening Medicare and Repaying Taxpayers Act of 2012
Client: BAXTER HEALTHCARE CORPORATION · Firm: BAXTER HEALTHCARE CORPORATION
HR 1845/S 960: Provide supplies and nursing services necessary for home infusion of IVIG to Medicare beneficiaries with Primary Immunodeficiency Diseases; Legislation to cut Medicare Part B Drug Reimbursement.Raise awareness with legislators about the barriers to and the importance of protecting access for home dialysis. HR 3613: Part D Beneficiary Appeals Fairness Act - Amends part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act, with respect to a prescription drug plan (PDP) that provides for any tiered cost-sharing within a formulary (including a structure that provides for different co-payment or coinsurance amounts for drugs in different tiers included within the formulary), to authorize a Medicare part D eligible individual enrolled in the plan to request an exception to the tiered cost-sharing structure.
Medicare IVIG Access and Strengthening Medicare and Repaying Taxpayers Act of 2012
Client: BAXTER HEALTHCARE CORPORATION · Firm: BAXTER HEALTHCARE CORPORATION
HR 1845/S 960: Provide supplies and nursing services necessary for home infusion of IVIG to Medicare beneficiaries with Primary Immunodeficiency Diseases; Legislation to cut Medicare Part B Drug Reimbursement.Raise awareness with legislators about the barriers to and the importance of protecting access for home dialysis.HR 3613: Part D Beneficiary Appeals Fairness Act - Amends part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act, with respect to a prescription drug plan (PDP) that provides for any tiered cost-sharing within a formulary (including a structure that provides for different co-payment or coinsurance amounts for drugs in different tiers included within the formulary), to authorize a Medicare part D eligible individual enrolled in the plan to request an exception to the tiered cost-sharing structure.
Part D Beneficiary Appeals Fairness Act
Client: BAXTER HEALTHCARE CORPORATION · Firm: BAXTER HEALTHCARE CORPORATION
HR 1845/S 960: Provide supplies and nursing services necessary for home infusion of IVIG to Medicare beneficiaries with Primary Immunodeficiency Diseases; Legislation to cut Medicare Part B Drug Reimbursement.Raise awareness with legislators about the barriers to and the importance of protecting access for home dialysis. HR 3613: Part D Beneficiary Appeals Fairness Act - Amends part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act, with respect to a prescription drug plan (PDP) that provides for any tiered cost-sharing within a formulary (including a structure that provides for different co-payment or coinsurance amounts for drugs in different tiers included within the formulary), to authorize a Medicare part D eligible individual enrolled in the plan to request an exception to the tiered cost-sharing structure.
Part D Beneficiary Appeals Fairness Act
Client: BAXTER HEALTHCARE CORPORATION · Firm: BAXTER HEALTHCARE CORPORATION
HR 1845/S 960: Provide supplies and nursing services necessary for home infusion of IVIG to Medicare beneficiaries with Primary Immunodeficiency Diseases; Legislation to cut Medicare Part B Drug Reimbursement.Raise awareness with legislators about the barriers to and the importance of protecting access for home dialysis.HR 3613: Part D Beneficiary Appeals Fairness Act - Amends part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act, with respect to a prescription drug plan (PDP) that provides for any tiered cost-sharing within a formulary (including a structure that provides for different co-payment or coinsurance amounts for drugs in different tiers included within the formulary), to authorize a Medicare part D eligible individual enrolled in the plan to request an exception to the tiered cost-sharing structure.
Part D Beneficiary Appeals Fairness Act
Client: BAXTER HEALTHCARE CORPORATION · Firm: BAXTER HEALTHCARE CORPORATION
HR 1845/S 960: Provide supplies and nursing services necessary for home infusion of IVIG to Medicare beneficiaries with Primary Immunodeficiency Diseases; Legislation to cut Medicare Part B Drug Reimbursement.Raise awareness with legislators about the barriers to and the importance of protecting access for home dialysis. HR 3613: Part D Beneficiary Appeals Fairness Act - Amends part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act, with respect to a prescription drug plan (PDP) that provides for any tiered cost-sharing within a formulary (including a structure that provides for different co-payment or coinsurance amounts for drugs in different tiers included within the formulary), to authorize a Medicare part D eligible individual enrolled in the plan to request an exception to the tiered cost-sharing structure.
Medicare IVIG Access and Strengthening Medicare and Repaying Taxpayers Act of 2012
Client: BAXTER HEALTHCARE CORPORATION · Firm: BAXTER HEALTHCARE CORPORATION
HR 1845/S 960: Provide supplies and nursing services necessary for home infusion of IVIG to Medicare beneficiaries with Primary Immunodeficiency Diseases; Legislation to cut Medicare Part B Drug Reimbursement.Raise awareness with legislators about the importance of protecting reimbursement for home dialysis.
Medicare IVIG Access and Strengthening Medicare and Repaying Taxpayers Act of 2012
Client: BAXTER HEALTHCARE CORPORATION · Firm: BAXTER HEALTHCARE CORPORATION
HR 1845/S 960: Provide supplies and nursing services necessary for home infusion of IVIG to Medicare beneficiaries with Primary Immunodeficiency Diseases; Legislation to expand the orphan drug exemption from the drug fee (PPACA) to include drugs that only treat rare diseases; Legislation that would expand the 340b drug discount program
Medicare IVIG Access and Strengthening Medicare and Repaying Taxpayers Act of 2012
Client: BAXTER HEALTHCARE CORPORATION · Firm: BAXTER HEALTHCARE CORPORATION
HR 1845/S 960: Provide supplies and nursing services necessary for home infusion of IVIG to Medicare beneficiaries with Primary Immunodeficiency Diseases; Legislation to cut Medicare Part B Drug Reimbursement.
Counterfeit Drug Enforcement Act of 2009
Client: BAXTER HEALTHCARE CORPORATION · Firm: BAXTER HEALTHCARE CORPORATION
H.R. 3200/S. 1796: To provide affordable, quality health care for all Americand and reduce the growth in health care spending. H.R. 3590: The Patient Protection Affordable Care Act. H.R. 4872: The Health Care and Education Reconciliation Act. H.R. 3962: To provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes. H.R. 2726: To amend the Federal Food, Drug, and Cosmetic Act to increase criminal penalties for the sale or trade of prescription drugs knowingly caused to be adulterated or misbranded, to modify requirements for maintaining records of the chain-of-custody of prescription drugs, to establish recall authority regarding drugs, and for other purposes. H.R. 4899: Supplemental Appropriations Act, 2010, specific focus on Health and Human Services Funding H.R. 759, the FDA Globalization Act, as it relates to drug safety and pedigree. 340B drug discount program Drug and device marketing and promotion Drug and biological product pricing and reimbursement Follow-on biologics Healthcare-acquired infections Health insurance reform Implementation of bundling provisions in H.R. 6331(110th Congress) Issues regarding 340B Medical product safety Prescription drug pedigree and anti-counterfeiting policy
America's Affordable Health Choices Act of 2009
Client: BAXTER HEALTHCARE CORPORATION · Firm: BAXTER HEALTHCARE CORPORATION
H.R. 3200/S. 1796: To provide affordable, quality health care for all Americand and reduce the growth in health care spending. H.R. 3590: The Patient Protection Affordable Care Act. H.R. 4872: The Health Care and Education Reconciliation Act. H.R. 3962: To provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes. H.R. 2726: To amend the Federal Food, Drug, and Cosmetic Act to increase criminal penalties for the sale or trade of prescription drugs knowingly caused to be adulterated or misbranded, to modify requirements for maintaining records of the chain-of-custody of prescription drugs, to establish recall authority regarding drugs, and for other purposes. H.R. 4899: Supplemental Appropriations Act, 2010, specific focus on Health and Human Services Funding H.R. 759, the FDA Globalization Act, as it relates to drug safety and pedigree. 340B drug discount program Drug and device marketing and promotion Drug and biological product pricing and reimbursement Follow-on biologics Healthcare-acquired infections Health insurance reform Implementation of bundling provisions in H.R. 6331(110th Congress) Issues regarding 340B Medical product safety Prescription drug pedigree and anti-counterfeiting policy
Medicare and Medicaid Extenders Act of 2010
Client: BAXTER HEALTHCARE CORPORATION · Firm: BAXTER HEALTHCARE CORPORATION
HR 759, the FDA Globalization Act as it relates to drug safety and pedigree 510(k) approval for medical devices Drug and device marketing and promotion HR 4994-Medicare and Medicaid Extenders Act of 2010 Drug and bilogical product pricing and reimbursement Follow-on biologics Healthcare-acquired infections Health insurance reform Implementation of bundling provisions in HR 633 (110th Congress) Issues regarding 340B Medical product safety Prescription drug predigree and anti-counterfeiting policy
Food and Drug Administration Globalization Act of 2009
Client: BAXTER HEALTHCARE CORPORATION · Firm: BAXTER HEALTHCARE CORPORATION
HR 759, the FDA Globalization Act as it relates to drug safety and pedigree 510(k) approval for medical devices Drug and device marketing and promotion HR 4994-Medicare and Medicaid Extenders Act of 2010 Drug and bilogical product pricing and reimbursement Follow-on biologics Healthcare-acquired infections Health insurance reform Implementation of bundling provisions in HR 633 (110th Congress) Issues regarding 340B Medical product safety Prescription drug predigree and anti-counterfeiting policy
Food and Drug Administration Globalization Act of 2009
Client: BAXTER HEALTHCARE CORPORATION · Firm: BAXTER HEALTHCARE CORPORATION
H.R. 3200/S. 1796: To provide affordable, quality health care for all Americand and reduce the growth in health care spending. H.R. 3590: The Patient Protection Affordable Care Act. H.R. 4872: The Health Care and Education Reconciliation Act. H.R. 3962: To provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes. H.R. 2726: To amend the Federal Food, Drug, and Cosmetic Act to increase criminal penalties for the sale or trade of prescription drugs knowingly caused to be adulterated or misbranded, to modify requirements for maintaining records of the chain-of-custody of prescription drugs, to establish recall authority regarding drugs, and for other purposes. H.R. 4899: Supplemental Appropriations Act, 2010, specific focus on Health and Human Services Funding H.R. 759, the FDA Globalization Act, as it relates to drug safety and pedigree. 340B drug discount program Drug and device marketing and promotion Drug and biological product pricing and reimbursement Follow-on biologics Healthcare-acquired infections Health insurance reform Implementation of bundling provisions in H.R. 6331(110th Congress) Issues regarding 340B Medical product safety Prescription drug pedigree and anti-counterfeiting policy
Food and Drug Administration Globalization Act of 2009
Client: BAXTER HEALTHCARE CORPORATION · Firm: BAXTER HEALTHCARE CORPORATION
H.R. 759, the FDA Globalization Act, as it relates to drug safety and pedigree. H.R. 4213: American Jobs and Closing Tax Loopholes Act of 2010, provisions relating to 340B 340B drug discount program 510(k) approval for medical devicesDrug and device marketing and promotion Drug and biological product pricing and reimbursement Follow-on biologics Healthcare-acquired infections Health insurance reform Implementation of bundling provisions in H.R. 6331(110th Congress) Issues regarding 340B Medical product safety Prescription drug pedigree and anti-counterfeiting policy
America's Healthy Future Act of 2009
Client: BAXTER HEALTHCARE CORPORATION · Firm: BAXTER HEALTHCARE CORPORATION
H.R. 3200/S. 1796: To provide affordable, quality health care for all Americand and reduce the growth in health care spending. H.R. 3590: The Patient Protection Affordable Care Act. H.R. 4872: The Health Care and Education Reconciliation Act. H.R. 3962: To provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes. H.R. 2726: To amend the Federal Food, Drug, and Cosmetic Act to increase criminal penalties for the sale or trade of prescription drugs knowingly caused to be adulterated or misbranded, to modify requirements for maintaining records of the chain-of-custody of prescription drugs, to establish recall authority regarding drugs, and for other purposes. H.R. 4899: Supplemental Appropriations Act, 2010, specific focus on Health and Human Services Funding H.R. 759, the FDA Globalization Act, as it relates to drug safety and pedigree. 340B drug discount program Drug and device marketing and promotion Drug and biological product pricing and reimbursement Follow-on biologics Healthcare-acquired infections Health insurance reform Implementation of bundling provisions in H.R. 6331(110th Congress) Issues regarding 340B Medical product safety Prescription drug pedigree and anti-counterfeiting policy
American Middle Class Tax (AMT) Relief Act of 2007
Client: BAXTER HEALTHCARE CORPORATION · Firm: BAXTER HEALTHCARE CORPORATION
H.R. 3200/S. 1796: To provide affordable, quality health care for all Americand and reduce the growth in health care spending. H.R. 3590: The Patient Protection Affordable Care Act. H.R. 4872: The Health Care and Education Reconciliation Act. H.R. 3962: To provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes. H.R. 2726: To amend the Federal Food, Drug, and Cosmetic Act to increase criminal penalties for the sale or trade of prescription drugs knowingly caused to be adulterated or misbranded, to modify requirements for maintaining records of the chain-of-custody of prescription drugs, to establish recall authority regarding drugs, and for other purposes. H.R. 4899: Supplemental Appropriations Act, 2010, specific focus on Health and Human Services Funding H.R. 759, the FDA Globalization Act, as it relates to drug safety and pedigree. 340B drug discount program Drug and device marketing and promotion Drug and biological product pricing and reimbursement Follow-on biologics Healthcare-acquired infections Health insurance reform Implementation of bundling provisions in H.R. 6331(110th Congress) Issues regarding 340B Medical product safety Prescription drug pedigree and anti-counterfeiting policy
Superfund Polluter Pays Act
Client: BAXTER HEALTHCARE CORPORATION · Firm: BAXTER HEALTHCARE CORPORATION
H.R. 3200/S. 1796: To provide affordable, quality health care for all Americand and reduce the growth in health care spending. H.R. 3590: The Patient Protection Affordable Care Act. H.R. 4872: The Health Care and Education Reconciliation Act. H.R. 3962: To provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes. H.R. 2726: To amend the Federal Food, Drug, and Cosmetic Act to increase criminal penalties for the sale or trade of prescription drugs knowingly caused to be adulterated or misbranded, to modify requirements for maintaining records of the chain-of-custody of prescription drugs, to establish recall authority regarding drugs, and for other purposes. H.R. 4899: Supplemental Appropriations Act, 2010, specific focus on Health and Human Services Funding H.R. 759, the FDA Globalization Act, as it relates to drug safety and pedigree. 340B drug discount program Drug and device marketing and promotion Drug and biological product pricing and reimbursement Follow-on biologics Healthcare-acquired infections Health insurance reform Implementation of bundling provisions in H.R. 6331(110th Congress) Issues regarding 340B Medical product safety Prescription drug pedigree and anti-counterfeiting policy
To suspend temporarily the duty on 1-Amino-2,6-dimethylbenzene.
Client: BAXTER HEALTHCARE CORPORATION · Firm: BAXTER HEALTHCARE CORPORATION
H.R. 3200/S. 1796: To provide affordable, quality health care for all Americand and reduce the growth in health care spending. H.R. 3590: The Patient Protection Affordable Care Act. H.R. 4872: The Health Care and Education Reconciliation Act. H.R. 3962: To provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes. H.R. 2726: To amend the Federal Food, Drug, and Cosmetic Act to increase criminal penalties for the sale or trade of prescription drugs knowingly caused to be adulterated or misbranded, to modify requirements for maintaining records of the chain-of-custody of prescription drugs, to establish recall authority regarding drugs, and for other purposes. H.R. 4899: Supplemental Appropriations Act, 2010, specific focus on Health and Human Services Funding H.R. 759, the FDA Globalization Act, as it relates to drug safety and pedigree. 340B drug discount program Drug and device marketing and promotion Drug and biological product pricing and reimbursement Follow-on biologics Healthcare-acquired infections Health insurance reform Implementation of bundling provisions in H.R. 6331(110th Congress) Issues regarding 340B Medical product safety Prescription drug pedigree and anti-counterfeiting policy
Community-Based Mental Health Infrastructure Improvements Act
Client: BAXTER HEALTHCARE CORPORATION · Firm: BAXTER HEALTHCARE CORPORATION
H.R. 3200/S. 1796: To provide affordable, quality health care for all Americand and reduce the growth in health care spending. H.R. 3590: The Patient Protection Affordable Care Act. H.R. 4872: The Health Care and Education Reconciliation Act. H.R. 3962: To provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes. H.R. 2726: To amend the Federal Food, Drug, and Cosmetic Act to increase criminal penalties for the sale or trade of prescription drugs knowingly caused to be adulterated or misbranded, to modify requirements for maintaining records of the chain-of-custody of prescription drugs, to establish recall authority regarding drugs, and for other purposes. H.R. 4899: Supplemental Appropriations Act, 2010, specific focus on Health and Human Services Funding H.R. 759, the FDA Globalization Act, as it relates to drug safety and pedigree. 340B drug discount program Drug and device marketing and promotion Drug and biological product pricing and reimbursement Follow-on biologics Healthcare-acquired infections Health insurance reform Implementation of bundling provisions in H.R. 6331(110th Congress) Issues regarding 340B Medical product safety Prescription drug pedigree and anti-counterfeiting policy
To amend the Lobbying Disclosure Act of 1995 to require lobbyists to disclose the candidates, leadership PACs, and political party committees for whom they collect or arrange contributions, and for other purposes.
Client: BAXTER HEALTHCARE CORPORATION · Firm: BAXTER HEALTHCARE CORPORATION
HR 759, the FDA Globalization Act as it relates to drug safety and pedigree 510(k) approval for medical devices Drug and device marketing and promotion HR 4994-Medicare and Medicaid Extenders Act of 2010 Drug and bilogical product pricing and reimbursement Follow-on biologics Healthcare-acquired infections Health insurance reform Implementation of bundling provisions in HR 633 (110th Congress) Issues regarding 340B Medical product safety Prescription drug predigree and anti-counterfeiting policy
Medicare Improvements for Patients and Providers Act of 2008
Client: BAXTER HEALTHCARE CORPORATION · Firm: BAXTER HEALTHCARE CORPORATION
H.R. 3200/S. 1796: To provide affordable, quality health care for all Americand and reduce the growth in health care spending. H.R. 3590: The Patient Protection Affordable Care Act. H.R. 4872: The Health Care and Education Reconciliation Act. H.R. 3962: To provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes. H.R. 2726: To amend the Federal Food, Drug, and Cosmetic Act to increase criminal penalties for the sale or trade of prescription drugs knowingly caused to be adulterated or misbranded, to modify requirements for maintaining records of the chain-of-custody of prescription drugs, to establish recall authority regarding drugs, and for other purposes. H.R. 4899: Supplemental Appropriations Act, 2010, specific focus on Health and Human Services Funding H.R. 759, the FDA Globalization Act, as it relates to drug safety and pedigree. 340B drug discount program Drug and device marketing and promotion Drug and biological product pricing and reimbursement Follow-on biologics Healthcare-acquired infections Health insurance reform Implementation of bundling provisions in H.R. 6331(110th Congress) Issues regarding 340B Medical product safety Prescription drug pedigree and anti-counterfeiting policy
Medicare Improvements for Patients and Providers Act of 2008
Client: BAXTER HEALTHCARE CORPORATION · Firm: BAXTER HEALTHCARE CORPORATION
H.R. 759, the FDA Globalization Act, as it relates to drug safety and pedigree. H.R. 4213: American Jobs and Closing Tax Loopholes Act of 2010, provisions relating to 340B 340B drug discount program 510(k) approval for medical devicesDrug and device marketing and promotion Drug and biological product pricing and reimbursement Follow-on biologics Healthcare-acquired infections Health insurance reform Implementation of bundling provisions in H.R. 6331(110th Congress) Issues regarding 340B Medical product safety Prescription drug pedigree and anti-counterfeiting policy
BAXTER HEALTHCARE CORPORATION via BAXTER HEALTHCARE CORPORATION
2012 · fourth_quarter · Q4
HR 1845/S 960: Provide supplies and nursing services necessary for home infusion of IVIG to Medicare beneficiaries with Primary Immunodeficiency Diseases; Legislation to cut Medicare Part B Drug Reimbursement.Raise awareness with legislators about the barriers to and the importance of protecting access for home dialysis. HR 3613: Part D Beneficiary Appeals Fairness Act - Amends part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act, with respect to a prescription drug plan (PDP) that provides for any tiered cost-sharing within a formulary (including a structure that provides for different co-payment or coinsurance amounts for drugs in different tiers included within the formulary), to authorize a Medicare part D eligible individual enrolled in the plan to request an exception to the tiered cost-sharing structure.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BAXTER HEALTHCARE CORPORATION via BAXTER HEALTHCARE CORPORATION
2012 · third_quarter · Q3
HR 1845/S 960: Provide supplies and nursing services necessary for home infusion of IVIG to Medicare beneficiaries with Primary Immunodeficiency Diseases; Legislation to cut Medicare Part B Drug Reimbursement.Raise awareness with legislators about the barriers to and the importance of protecting access for home dialysis. HR 3613: Part D Beneficiary Appeals Fairness Act - Amends part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act, with respect to a prescription drug plan (PDP) that provides for any tiered cost-sharing within a formulary (including a structure that provides for different co-payment or coinsurance amounts for drugs in different tiers included within the formulary), to authorize a Medicare part D eligible individual enrolled in the plan to request an exception to the tiered cost-sharing structure.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BAXTER HEALTHCARE CORPORATION via BAXTER HEALTHCARE CORPORATION
2012 · second_quarter · Q2
HR 1845/S 960: Provide supplies and nursing services necessary for home infusion of IVIG to Medicare beneficiaries with Primary Immunodeficiency Diseases; Legislation to cut Medicare Part B Drug Reimbursement.Raise awareness with legislators about the barriers to and the importance of protecting access for home dialysis.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BAXTER HEALTHCARE CORPORATION via BAXTER HEALTHCARE CORPORATION
2012 · first_quarter · Q1
HR 1845/S 960: Provide supplies and nursing services necessary for home infusion of IVIG to Medicare beneficiaries with Primary Immunodeficiency Diseases; Legislation to cut Medicare Part B Drug Reimbursement.Raise awareness with legislators about the barriers to and the importance of protecting reimbursement for home dialysis.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
BAXTER HEALTHCARE CORPORATION via BAXTER HEALTHCARE CORPORATION
2011 · fourth_quarter · Q4
HR 1845/S 960: Provide supplies and nursing services necessary for home infusion of IVIG to Medicare beneficiaries with Primary Immunodeficiency Diseases; Legislation to cut Medicare Part B Drug Reimbursement.Raise awareness with legislators about the importance of protecting reimbursement for home dialysis.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
BAXTER HEALTHCARE CORPORATION via BAXTER HEALTHCARE CORPORATION
2011 · third_quarter · Q3
HR 1845/S 960: Provide supplies and nursing services necessary for home infusion of IVIG to Medicare beneficiaries with Primary Immunodeficiency Diseases; Legislation to cut Medicare Part B Drug Reimbursement.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BAXTER HEALTHCARE CORPORATION via BAXTER HEALTHCARE CORPORATION
2011 · second_quarter · Q2
HR 1845/S 960: Provide supplies and nursing services necessary for home infusion of IVIG to Medicare beneficiaries with Primary Immunodeficiency Diseases; Legislation to expand the orphan drug exemption from the drug fee (PPACA) to include drugs that only treat rare diseases; Legislation that would expand the 340b drug discount program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BAXTER HEALTHCARE CORPORATION via BAXTER HEALTHCARE CORPORATION
2010 · fourth_quarter · Q4
HR 759, the FDA Globalization Act as it relates to drug safety and pedigree 510(k) approval for medical devices Drug and device marketing and promotion HR 4994-Medicare and Medicaid Extenders Act of 2010 Drug and bilogical product pricing and reimbursement Follow-on biologics Healthcare-acquired infections Health insurance reform Implementation of bundling provisions in HR 633 (110th Congress) Issues regarding 340B Medical product safety Prescription drug predigree and anti-counterfeiting policy
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE, State, Dept of (DOS)
BAXTER HEALTHCARE CORPORATION via BAXTER HEALTHCARE CORPORATION
2010 · third_quarter · Q3
H.R. 759, the FDA Globalization Act, as it relates to drug safety and pedigree. H.R. 4213: American Jobs and Closing Tax Loopholes Act of 2010, provisions relating to 340B 340B drug discount program 510(k) approval for medical devicesDrug and device marketing and promotion Drug and biological product pricing and reimbursement Follow-on biologics Healthcare-acquired infections Health insurance reform Implementation of bundling provisions in H.R. 6331(110th Congress) Issues regarding 340B Medical product safety Prescription drug pedigree and anti-counterfeiting policy
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Natl Economic Council (NEC), SENATE, State, Dept of (DOS)
BAXTER HEALTHCARE CORPORATION via BAXTER HEALTHCARE CORPORATION
2010 · second_quarter · Q2
H.R. 3200/S. 1796: To provide affordable, quality health care for all Americand and reduce the growth in health care spending. H.R. 3590: The Patient Protection Affordable Care Act. H.R. 4872: The Health Care and Education Reconciliation Act. H.R. 3962: To provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes. H.R. 2726: To amend the Federal Food, Drug, and Cosmetic Act to increase criminal penalties for the sale or trade of prescription drugs knowingly caused to be adulterated or misbranded, to modify requirements for maintaining records of the chain-of-custody of prescription drugs, to establish recall authority regarding drugs, and for other purposes. H.R. 4899: Supplemental Appropriations Act, 2010, specific focus on Health and Human Services Funding H.R. 759, the FDA Globalization Act, as it relates to drug safety and pedigree. 340B drug discount program Drug and device marketing and promotion Drug and biological product pricing and reimbursement Follow-on biologics Healthcare-acquired infections Health insurance reform Implementation of bundling provisions in H.R. 6331(110th Congress) Issues regarding 340B Medical product safety Prescription drug pedigree and anti-counterfeiting policy
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Natl Economic Council (NEC), SENATE, State, Dept of (DOS)